Boussard & Gavaudan Investment Management »

Horizon Therapeutics shares owned by Boussard & Gavaudan Investment Management

Quarter-by-quarter ownership of Horizon Therapeutics shares owned by Boussard & Gavaudan Investment Management from 13F filings

Historical chart of Boussard & Gavaudan Investment Management investment in Horizon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Horizon Therapeutics held by Boussard & Gavaudan Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Horizon Therapeutics by Boussard & Gavaudan Investment Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $81M 696k 115.68
2023-06-30 $74M 722k 103.01
2023-03-31 $61M 564k 109.01

More positions owned by Boussard & Gavaudan Investment Management

Activision Blizzard
Horizon Therapeutics Pub L SHS
Chart Inds Note 1.000%11/1
Vmware Cl A Com
Seagen
Cnx Res Corp Note 2.250% 5/0
Booking Holdings Note 0.750% 5/0
Altair Engr Note 0.250% 6/0
Permian Resources Corp Note 3.250% 4/0
On Semiconductor Corp Note 5/0
Westrock (WRK)
Bgc Group Cl A (BGC)
Ambac Finl Group Com New (AMBC)
Cinemark Hldgs Note 4.500% 8/1
Dynavax Technologies Corp Note 2.500% 5/1

View all positions for Boussard & Gavaudan Investment Management

Top funds holding Horizon Therapeutics

IFP Advisors
Ronald Blue Trust
Beacon Capital Management
Huntington National Bank

View all funds holding Horizon Therapeutics